Skip to Content

L009 (Levetiracetam extended release 750 mg)

Pill imprint L009 has been identified as Levetiracetam extended release 750 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; neuralgia; new daily persistent headache; bipolar disorder (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Levetiracetam extended release 750 mg L009
Levetiracetam extended release
Imprint:
L009
Strength:
750 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC):
68180-0118
Inactive Ingredients:
calcium phosphate dibasic anhydrous
lactose anhydrous
silicon dioxide colloidal
ferric oxide black
hydrogenated cottonseed oil
hypromellose 2910 (5 mPa.s)
magnesium stearate
polyethylene glycol
polyvinyl alcohol
propylene glycol
shellac
magnesium silicate
titanium dioxide

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide